Dorval Allison
Verve Therapeutics, Inc. · Chief Financial Officer
Dorval Allison is listed in public filings as officer: Chief Financial Officer. This Dorval Allison insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Verve Therapeutics, Inc. (VERV), and Puma Biotechnology, Inc. (PBYI). Investors use Dorval Allison's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0180k shares | OtherJul 25, 2025 | $2.3M180k shares | $12.75 | -- | |
| $075k shares | OtherJul 25, 2025 | $450.8K75k shares | $6.01 | -- | |
| --1.9k shares | OtherJul 25, 2025 | Disclosure amount unavailable1.9k shares | -- | -- | |
| $013.3k shares | OtherJul 25, 2025 | $139.4K13.3k shares | $10.50 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $256k75.4k shares | SellJun 13, 2025 | $39.5K11.6k shares | $3.40 | -- | |
| --87k shares | Grant / ExerciseJun 11, 2025 | Disclosure amount unavailable27k shares | -- | -- | |
| $55k13.3k shares | SellApr 2, 2025 | $13.9K3.4k shares | $4.15 | -- | |
| --16.6k shares | Grant / ExerciseApr 1, 2025 | Disclosure amount unavailable11.3k shares | -- | -- | |
| $1.6M258k shares | Grant / ExerciseJan 8, 2025 | $1.6M258k shares | $6.01 | -- | |
| $451k75k shares | Grant / ExerciseJan 8, 2025 | $450.8K75k shares | $6.01 | -- | |
| --45k shares | Grant / ExerciseJan 8, 2025 | Disclosure amount unavailable45k shares | -- | -- | |
| $30k5.4k shares | SellDec 2, 2024 | $3.1K555 shares | $5.64 | -- | |
| --1.9k shares | Grant / ExerciseNov 29, 2024 | Disclosure amount unavailable1.9k shares | -- | -- | |
| --60k shares | Grant / ExerciseJun 18, 2024 | Disclosure amount unavailable27k shares | -- | -- | |
| $111k33k shares | SellJun 13, 2024 | $37.1K11k shares | $3.37 | -- |